Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CDNA
    4. >
  4. Valuation

Valuation

-
stocks logo
CDNA
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is CDNA Overvalued？

CDNA is now in the zone, suggesting that CDNA current forward PE ratio of 31.24 is considered compare with the five-year average of 56.68.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

CDNA Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
CDNA.O
CareDx Inc
31.24
Average P/E: 145.82
150.61%
1.05B
stocks logo
PLSE.O
Pulse Biosciences Inc
loss
Average P/E: 145.82
-7.93%
1.04B
stocks logo
AORT.N
Artivion Inc
376.88
Average P/E: 145.82
-338.31%
1.01B
stocks logo
FNA.N
Paragon 28 Inc
loss
Average P/E: 145.82
-9.31%
1.09B
stocks logo
GRAL.O
Grail Inc
loss
Average P/E: 145.82
1.01B
stocks logo
MDXG.O
MiMedx Group Inc
29.33
Average P/E: 145.82
-81.15%
1.17B

CDNA Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

CDNA FAQs

Is CDNA currently overvalued based on its P/E ratio?

According to the provided data, CDNA's 5-year historical average forward P/E ratio is 56.72. CDNA forward P/E ratio is 31.24, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for CDNA?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has CDNA's Price to Sales (PS) ratio evolved?

The PS ratio decreased from 5.25 to 3.63, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for CDNA's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

CDNA PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
56.68
Current PE
31.24
Overvalued PE
270.49
Undervalued PE
-157.13

CDNA EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
33.79
Current EV
23.78
Overvalued EV
165.74
Undervalued EV
-98.16

CDNA P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
5.80
Current PS
2.64
Overvalued PS
10.10
Undervalued PS
1.51

CDNA Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
CDNA.O
CareDx Inc
31.24
Average P/E: 145.82
150.61%
1.05B
stocks logo
PLSE.O
Pulse Biosciences Inc
loss
Average P/E: 145.82
-7.93%
1.04B
stocks logo
AORT.N
Artivion Inc
376.88
Average P/E: 145.82
-338.31%
1.01B
stocks logo
FNA.N
Paragon 28 Inc
loss
Average P/E: 145.82
-9.31%
1.09B
stocks logo
GRAL.O
Grail Inc
loss
Average P/E: 145.82
1.01B
stocks logo
MDXG.O
MiMedx Group Inc
29.33
Average P/E: 145.82
-81.15%
1.17B

CDNA Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is CDNA undervalued？Is CDNA overvalued compared to its competitors？

CDNA FAQs

Is CDNA currently overvalued based on its P/E ratio?

According to the provided data, CDNA's 5-year historical average forward P/E ratio is 56.72. CDNA forward P/E ratio is 31.24, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for CDNA?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has CDNA's Price to Sales (PS) ratio evolved?

The PS ratio decreased from 5.25 to 3.63, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for CDNA's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is CDNA undervalued？Is CDNA overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free